Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1379-1382

  Ulusoy, Hasan ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Fibrodysplasia ossificans progressiva; Heterotopic ossification; Myositis ossificans progressiva

Indexed keywords

C REACTIVE PROTEIN; ETIDRONIC ACID;

ADULT; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FOLLOW UP; HUMAN; JOINT; LIMB WEAKNESS; MALE; OSSIFICATION; OSSIFYING MYOSITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETON MALFORMATION; SOFT TISSUE; THIGH;

ADULT; BIOMECHANICS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSITIS OSSIFICANS; OSSIFICATION, HETEROTOPIC; PHYSICAL THERAPY MODALITIES; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 84863632654     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1426-1     Document Type: Article

References (31)

1. Smith R (1998) Fibrodysplasia (myosistis) ossificans progressiva: clinical lessons from a rare disease. Clin Orthop 346:7-14
2. Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102:314-317
3. Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:201-204
4. Mahboubi S, Glaser DL, Shore EM, Kaplan FS (2001) Fibro-dysplasia ossificans progressiva. Pediatr Radiol 31:307-314
5. Puszczewicz M, Kolczewska A, Gorska IZ, Majewski D, Ogrodowicz A (2007) Fibrodysplasia ossificans progressiva: case report. Pol Arch Med Wewn 117:53-56
6. Palhares DB, Leme LM (2001) A perspective on the control of myositis ossificans progressiva. J Pediatr (Rio J) 77:431-434
7. Connor JM, Evans DAP (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg 64(B):76-83
8. Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J et al (2009) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:1295-1300
9. Rogers JG, Geho WB (1979) Fibrodysplasia ossificans pro-gressiva. A survey of forty-two cases. J Bone Joint Surg 61A:909-914
10. Schroeder HW, Zasloff MA (1980) The hand and foot malformations in fibrodysplasia ossificans progressiva. Johns Hopkins Med J 147:73-78
11. Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A et al (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 75:215-219
12. Kaplan FS, Merrer ML, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA et al (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191-205
13. Pignolo RJ, Suda RK, Kaplan FS (2005) The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 3:195-200
14. Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS (1997) Limb swelling in patients who have fibrodys-plasia ossificans progressiva. Clin Orthop Rel Res 336:247-253
15. Kussmaul WG, Esmail AN, Sagir AN, Ross J, Gregory S, Kaplan FS (1998) Pulmonary and cardiac function in advanced fibro-dysplasia ossificans progressiva. Clin Orthop 346:104-109
16. Schaffer AA, Kaplan FS, Tracy MR, O'Brien ML, Dormans JP, Shore EM et al (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine 30:1379-1385
17. Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P et al (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183-188
18. Miller ES, Esterly NB, Fairley JA (1996) Progressive osseous heteroplasia. Arch Dermatol 132:787-791
19. Sanmartin O, Alegre V, Martinez-Aparicio A, Botella-Estrada R, Aliaga A (1993) Congenital platelike osteoma cutis: case report and review of the literature. Pediatr Dermatol 10:182-186
20. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 322:1412-1419
21. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progress-iva. Nat Genet 38:525-527
22. Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY et al (2009) ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci 24:433-437
23. Furuya H, Ikezoe K, Wang L, Ohyagi Y, Motomura K, Fujii N et al (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 146:459-463
24. Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 17:311-318
25. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L et al (2009) Classic and atypical fibrodysplasia ossificans pro-gressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30:379-390
26. Buyse G, Silberstein J, Goemans N, Casaer P (1995) Fibrodys-plasia Ossificans Progressiva: still turning into wood after 300 years? Eur J Pediatr 154:694-699
27. Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:243-250
28. Kaplan FS, Shore EM, Glaser DL, Emerson S (2003) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Consort FOP 1:1-81
29. Kaplan FS, Shore EM, Glaser DL, Emerson S (2005) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 1:1-71
30. Blaszczyk M, Majewski S, Wcislo LB, Jablonska S (2003) Fibrodysplasia ossificans progressiva. Eur J Dermatol 13:234-237
31. Nucci A, Queiroz LDS, Santos ADO, Camargo E, Moura RM (2000) Fibrodysplasia ossificans progressiva. Arq Neuropsiquiatr 58:342-347